• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » China’s Venus Medtech launches CE Mark trial for pulmonary valve replacement

China’s Venus Medtech launches CE Mark trial for pulmonary valve replacement

September 19, 2016 By Fink Densford

Venus MedicalChinese heart valve maker Venus Medtech said today that it launched a clinical trial to support CE Mark approval in the European Union for its Venus P transcatheter pulmonary valve, designed to treat pulmonary regurgitation.

The company said the 1st patient in the trial was implanted last week with the Venus P valve at London’s Evelina Children’s Hospital by Dr. Shakeel Qureshi, principal investigator for the study.

The 1st phase of the trial includes 6 locations and is looking to enroll 80 to 100 patients across Europe, with Venus Medtech touting the trial as the the 1st formal clinical trial at multiple locations in Europe to use a China-made transcatheter valve, according to a press release.

In April, Venus Medtech acquired Regensburg, Germany-based Transcatheter Technologies for an undisclosed amount.

Transcatheter Technologies makes the Trinity transcatheter aortic valve replacement, which it touts as the only TAVR device that’s “truly” repositionable, even after full implantation. Trinity is also designed to minimize or eliminate the paravalvular leakage that’s plagued early TAVR devices, the company has said.

Venus Medtech said it plans to use Transcatheter Technologies portfolio as the basis for the next generation of its TAVR device. The company’s Venus A-Valve has completed the clinical trial phase and is awaiting approval by the China Food & Drug Administration. A transcatheter pulmonary valve replacement is in trials; together, Transcatheter Technologies said, they are expected to be the 1st transcatheter heart valve replacements approved by the People’s Republic.

Filed Under: Cardiovascular, Clinical Trials, Replacement Heart Valves Tagged With: Venus Medtech

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy